Potential End of ACA Subsidies Will Affect Sales, Brokers

California is one of several states that will be dramatically affected if Congress takes no action to extend the enhanced Affordable Care Act (ACA) subsidies authorized as part of the 2021 American Rescue Plan Act (ARPA) and extended through 2025 by the 2022 Inflation Reduction Act (IRA).

The enhanced subsidies reduce the premium for eligible individuals buying ACA health plans through Covered California, other state exchanges, and the federal exchange Marketplace, HealthCare.gov. They expanded eligibility beyond the original ACA income gap of 400% of the federal poverty level (FPL). In 2025, the FPL for a single person is $15,560. For a family of four, it is $32,150. For more information on poverty guidelines, visit the U.S. Department of Health & Human Services website.

If Congress does not extend the enhanced subsidies, it is expected that the average Marketplace premium could increase significantly – potentially doubling in some states. That likely would result in many enrollees dropping their insurance or moving to a less comprehensive health plan.

In California, the end of the ACA enhanced subsidies will affect not just those paying a reduced premium, but all 2.37 million Californians in the individual marketplace. The University of California Berkeley Labor Center estimates 1.56 million Californians will pay an average of $967 more annually, if they maintain their Marketplace coverage. Another 750,000 enrolled in unsubsidized coverage will pay $253 more per year. Nearly 70,000 will become uninsured.

The projection by the Labor Center forecasts an average increase for Covered California premiums of $967 per year beginning in 2026, absent any action by Congress or the state. Families USA, a leading national, non-partisan nonprofit dedicated to affordable health care and improved health for all, says single Californians in their mid-40s making $30,000 annually would see their monthly premiums increase by $1,350 per year. Couples in their early 60s earning $80,000 would see a bump pf $17,050 annually.

It is unknown whether members of Congress will feel any pressure from their constituents to renew the ACA subsidies. Making them permanent would cost $383 billion over 10 years according to the Congressional Budget Office (CBO). A temporary extension is possible, since KFF (the former Kaiser Family Foundation) estimates more than half of ACA enrollees live in Republican districts in the U.S. House of Representatives.

Watch for updates on the potential elimination of ACA subsidies in the months ahead.

 

Source Link

Recommended Articles

Trump Administration Demands Hospitals Share Emergency Room Records

A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that some of the nation’s biggest health systems turn over detailed, personally identifiable medical records of all patients who seek help at their emergency rooms. The Consumer Product Safety Commission, responsible for tracking and issuing recalls ...

Read More

21 States File Lawsuit Challenging 2027 ACA Payment Rule

A coalition of attorneys general from 21 states, along with Pennsylvania Gov. Josh Shapiro, have filed a lawsuit challenging a federal rule that they allege undermines the Affordable Care Act and makes health insurance more expensive and harder to obtain for millions of Americans. The lawsuit seeks to block provisions of the Trump administration’s ACA ...

Read More

Erica Schwartz, Trump’s CDC Pick Wins Senate Confirmation

The Senate voted to confirm President Donald Trump’s nominee, Erica Schwartz, to run the Centers for Disease Control and Prevention on Wednesday, ending a nearly yearlong period without a Senate-confirmed director leading the agency. Schwartz was confirmed in a 51-44 vote, with Sen. Tim Kaine (D-Va.) joining Republicans in support. All other Democrats opposed the nomination. Despite a ...

Read More

Specialty Drug Costs Expected To Jump 32% By 2028, PSG Finds

Specialty drug trend remains high, although it decreased from 11.2% to 10.8% on a gross cost basis in Pharmacy Strategies Group’s 2026 State of Specialty Spend and Trend Report. Claim utilization is now the dominant driver of specialty drug trend as the percentage of members using specialty drugs rose to 5.5%. “For a decade, this report ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square